Livongo - About the company
Livongo is an acquired company based in San Francisco (United States), founded in 2014 by Glen Tullman. It operates as a Provider of smart devices for diabetes management for patients and doctors. Livongo has raised $245M in funding from investors like General Catalyst, Kinnevik and DFJ, with last known valuation of $*****. The company has 315 active competitors, including 80 funded and 28 that have exited. Its top competitors include companies like Dexcom, Insulet and Senseonics.
Company Details
Provider of smart devices for diabetes management for patients and doctors. It offers devices for diabetic patients to track and monitor their blood glucose levels. It also provides a blood pressure monitoring system and weighing scale for weight management. In addition, it offers a mobile app for users to receive personalized tips, nutrition and diet recommendation, and exercise information to manage blood sugar and pressure.
- Website
- livongo.com
- Phone Number
- +1 **********
Key Metrics
Founded Year
2014
Location
San Francisco, United States
Stage
Acquired
Total Funding
$245M in 8 rounds
Latest Funding Round
Last Known Valuation
$***** as on May 28, 2025
Investors
Ranked
5th among 315 active competitors
Annual Revenue
$100M - $500M as on Dec 31, 2019
Employee Count
79 as on Jul 31, 2026
Exit Details
Acquired by Teladoc Health (Aug 05, 2020)
Legal entities associated with Livongo
Livongo is associated with 2 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
LIVONGO HEALTH, INC. CIN: 1639225 , United States, Active | Oct 15, 2008 | $100M - $500M (As on Dec 31, 2019) | 3263 (As on Dec 31, 2023) | - |
TELADOC HEALTH, INC CIN: 4596317 , United States, Active | $1B+ (As on Dec 31, 2023) | - | - |
Livongo's acquisition details
Livongo got acquired by Teladoc Health on Aug 05, 2020.
Click here to take a look at Livongo's acquisition in detail
Sign up to download Livongo's company profile
Livongo's funding and investors
Livongo has raised a total funding of $245M over 8 rounds. Its first funding round was on Apr 21, 2014. Livongo has 22 institutional investors and 1 angel investor.
Here is the list of recent funding rounds of Livongo:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jun 02, 2020 | 8975776 | Post IPO | 7936330 | 9946088 | 1528198 | 6123894 |
Apr 11, 2018 | 8655798 | Series E | 7232444 | 7592567 | 6727648 | |
Mar 16, 2017 | 1709064 | Series D | 3262669 | 9803188 |
View details of Livongo's funding rounds and investors
Livongo's founders and board of directors
Founder? Claim ProfileThe founders of Livongo is Glen Tullman.
Here are the details of Livongo's key team members:
- Glen Tullman: Former Founder of Livongo and founder of 1 other company. They are also an angel investor in 5 startups.
View details of Livongo's Founder profiles and Board Members
Livongo's employee count trend
Livongo has 79 employees as of Jul 26. Here is Livongo's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Livongo's Competitors and alternates
Top competitors of Livongo include Dexcom, Insulet and Senseonics. Here is the list of Top 10 competitors of Livongo, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Dexcom 1999, San Diego (United States), Public | Provider of a wearable device for glucose monitoring | $52.7M | 79/100 | |
2nd | Insulet 2000, Boston (United States), Public | Manufacturer of wearable, tubeless insulin delivery systems for diabetes management | $120M | 77/100 | |
3rd | Senseonics 1996, Germantown (United States), Public | Provider of implantable systems for continuous glucose monitoring | $165M | 71/100 | |
4th | Signos 2020, San Francisco (United States), Series B | Provider of a wearable device for blood glucose pattern monitoring | $57M | 71/100 | |
5th | Livongo 2014, San Francisco (United States), Acquired | Provider of smart devices for diabetes management for patients and doctors | $245M | 69/100 | |
6th | Gamification apps for diabetes management and therapy | $4.8M | 70/100 | ||
7th | Provider of diabetes care and reversal programs | $26.7M | 68/100 | ||
8th | One Drop 2015, New York City (United States), Series C | Provider of workforce healthcare solutions | $108M | 65/100 | |
9th | Jana Care 2011, Newton (United States), Series C | Provider of mobile-based healthcare diagnostics for diabetes prevention | $35.7M | 63/100 | |
10th | Liom 2017, Pfaffikon (Switzerland), Series A | Platform offering non invasive glucose monitoring solutions | $79.3M | 63/100 |
Looking for more details on Livongo's competitors? Click here to see the top ones
Livongo's Investments and acquisitions
Livongo has made 1 investments in companies including Homeward. Livongo has also acquired 3 companies including myStrength and Retrofit.Here is the list of investments & acquisitions:
Filter this list
Date of Investment/Acquisition | Type | Company Name | Founded Year | Location |
|---|---|---|---|---|
Mar 07, 2022 | Investments | 2021 | San Francisco (United States) | |
Jan 30, 2019 | Acquisition | 2010 | Denver (United States) | |
Apr 17, 2018 | Acquisition | 2011 | Chicago (United States) |
See all acquisitions by Livongo
Reports related to Livongo
Here is the latest report on Livongo's sector:
News related to Livongo
•
Telenutrition Company Foodsmart Adds 3 Health SystemsHealthcare Innovation•Feb 01, 2024•Foodsmart, Advocate Health, Memorial Hermann, Intermountain Healthcare and 4 others
•
Teladoc’s Victory in Securities Class Action Arising from Livongo AcquisitionGlobal Legal Chronicle•Jul 14, 2023•Teladoc Health, Livongo, Paul, Weiss, Rifkind, Wharton & Garrison
•
Judge tosses suit alleging Teladoc misled investorsBecker's Hospital Review•Jul 08, 2023•Teladoc Health, Livongo
•
Digital Health Product Leader, Eitan Shay, Joins Dario as Chief Product OfficerPR Newswire•Apr 04, 2023•DarioHealth, Livongo, Sanofi
•
Teladoc sinks $13.7B loss in 2022 tied to plummeting value of Livongo acquisitionFierce Healthcare•Feb 24, 2023•Teladoc Health, Livongo
•
Digital gastrointestinal care startup Salvo Health launches with $10.5MMobiHealthNews•Aug 08, 2022•Torch Capital, Threshold, Felicis Ventures, Salvo and 5 others
•
Teladoc reports $6.6B impairment charge for Livongo acquisitionBecker's Hospital Review•Apr 28, 2022•Teladoc Health, Livongo
•
Rural Health Startup Homeward Emerges with $20M to Support Rural CommunitiesHIT Consultant•Mar 11, 2022•Homeward, General Catalyst, Livongo
•
•
Are you a Founder ?
FAQs about Livongo
Explore our recently published companies
